Clinical trial No longer in our active list Interventional Ages 18 to 65

Rehabilitation for Achilles tendon rupture using electrical stimulation

Official title: Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation

Run by Penn State University · NCT04727047 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new way to help people recover from Achilles tendon ruptures by using electrical stimulation to strengthen their calf muscles and improve tendon health.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorPenn State University
Academic / other
Locations1 site (State College, Pennsylvania)
Trial IDNCT04727047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who have suffered an Achilles tendon rupture and are capable of understanding and consenting to the study.

Probably not a fit

Patients who have undergone non-operative treatment or have additional health conditions that impair healing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate a new rehabilitation protocol utilizing Neuromuscular Electrical Stimulation (NMES) to address long-term functional deficits in patients with Achilles tendon ruptures. The protocol focuses on reducing muscle atrophy and improving tendon properties by applying controlled electrical stimulation to the calf muscles, which can induce low-magnitude cyclic loading to the tendon. This approach is designed to counteract the negative effects of tendon elongation and muscle atrophy that commonly occur during recovery. If successful, the NMES protocol could be easily integrated into standard care for these patients.

Why it matters

Potential benefit: If successful, this approach could significantly enhance recovery outcomes for patients with Achilles tendon ruptures by improving muscle strength and tendon function.

How similar studies have gone: While the use of NMES in rehabilitation is not entirely novel, this specific application for Achilles tendon rupture is innovative and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Achilles tendon rupture

Exclusion Criteria:

1. Those unable to understand spoken English.
2. Participants treated non-operatively
3. Augmented surgical repair (i.e., use of additional tissue at the repair site)
4. Tendon ruptures associated with the use of fluoroquinolones (Examples include ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), and ofloxacin (Floxin))
5. Allergy to ultrasound gel
6. Any other condition affecting the ability of the participant to walk or jump
7. Any other health conditions known to impair normal healing: Diabetes, Cardiovascular conditions decreasing blood supply to the leg
8. Those unable to consent

Where it's running

  • Penn State University
    State College, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.